Evidence map›Paper›PMID 32550154›Full record

ArticleJournal of diabetes and metabolic disorders2020

Initial experiences of adolescents and young adults with type 1 diabetes and high-risk glycemic control after starting flash glucose monitoring - a qualitative study.

Sara Boucher, Miranda Blackwell, Barbara Galland, Martin de Bock, Hamish Crocket, Esko Wiltshire, Paul Tomlinson, Jenny Rayns, Benjamin Wheeler

Open access · greenAbstract read
In one paragraph

Article in Journal of diabetes and metabolic disorders, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Development and Validation of a Distress Measurement Related to Glucose Monitoring of Diabetes Patients.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2023
    Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Sara BoucherDepartment of Women's and Children's Health, Dunedin School of Medicine, University of Otago, PO Box 56, Dunedin, 9054 New Zealand.ORCID 0000-0002-8358-881X
Miranda BlackwellDepartment of Women's and Children's Health, Dunedin School of Medicine, University of Otago, PO Box 56, Dunedin, 9054 New Zealand.
Barbara GallandDepartment of Women's and Children's Health, Dunedin School of Medicine, University of Otago, PO Box 56, Dunedin, 9054 New Zealand.ORCID 0000-0002-2376-3575
Martin de BockDepartment of Paediatrics, University of Otago, Floor 3, Terrace House, 4 Oxford Terrace, Christchurch, 8011 New Zealand.ORCID 0000-0002-6998-7566
Hamish CrocketFaculty of Health, Sport and Human Performance, University of Waikato, Gate 1, Knighton Road, Hamilton, 3240 New Zealand.ORCID 0000-0002-7134-6776
Esko WiltshireDepartment of Paediatrics and Child Health, University of Otago, PO Box 7343, Newtown, Wellington 6242 New Zealand.ORCID 0000-0002-8962-2708
Paul TomlinsonDepartment of Women's and Children's Health, Dunedin School of Medicine, University of Otago, PO Box 56, Dunedin, 9054 New Zealand.
Jenny RaynsSouthern District Health Board, 201 Great King Street, Dunedin, 9016 New Zealand.
Benjamin WheelerDepartment of Women's and Children's Health, Dunedin School of Medicine, University of Otago, PO Box 56, Dunedin, 9054 New Zealand.ORCID 0000-0003-3348-5238
Dunedin Public Hospital · NZCanterbury District Health Board · NZCapital and Coast District Health Board · NZSouthern District Health Board · NZUniversity of Waikato · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study explored early experiences with a flash glucose monitoring system among adolescents and young adults with type 1 diabetes and high-risk glycemic control.

methodsAdolescents and young adults with high-risk glycemic control (HbA1c ≥ 75 mmol/mol (9.0%) in the previous 6 months) who had recently commenced on flash glucose monitoring as part of a trial took part in a semi-structured interview exploring their experiences with the technology. All interviews were recorded, transcribed and analyzed using an inductive approach.

resultsFifteen interviews were conducted. Overall, participants enjoyed flash glucose monitoring and planned to continue using their system. Key findings included flash glucose monitoring reduced diabetes management burden and increased glucose monitoring. Other impacts of flash glucose monitoring use included perceived improved mood and energy, increased capacity for physical activity and less parental conflict. While participants reported healthier glycemic control, participants' mean interstitial glucose level remained above the target range of 3.9-10.0 mmol/L (70-180 mg/dL) over the first month of flash glucose monitoring. Common challenges included premature sensor loss and decreased scanning over the first month of use.

conclusionsFlash glucose monitoring may be an acceptable self-management tool to increase monitoring frequency in adolescents and young adults with type 1 diabetes and high-risk glycemic control, with the potential to improve long-term glycemic control. Initial support efforts should focus on practical strategies to prolong sensor wear and motivate frequent scanning as well as education on interpreting glucose data and making informed treatment decisions to maximize the benefits of this technology.

Indexed as

AdolescentsFlash glucose monitoringPatient experienceQualitativeTechnologyType 1 diabetesYoung adults

Identifiers

PMID32550154
PMCPMC7271079
OpenAlexW2993748045

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.